Conflicting Evidence on the Frequency of ESR1 Amplification in Breast Cancer
Authors
Affiliations
Ferro A, Campora M, Caldara A, De Lisi D, Lorenzi M, Monteverdi S J Clin Med. 2024; 13(12).
PMID: 38930141 PMC: 11204965. DOI: 10.3390/jcm13123611.
Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer.
Basudan A, Priedigkeit N, Hartmaier R, Sokol E, Bahreini A, Watters R Mol Cancer Res. 2018; 17(2):457-468.
PMID: 30355675 PMC: 6359977. DOI: 10.1158/1541-7786.MCR-18-0946.
Rangel N, Forero-Castro M, Rondon-Lagos M Genes (Basel). 2017; 8(6).
PMID: 28587191 PMC: 5485519. DOI: 10.3390/genes8060155.
Amplification of HER2 and TOP2A and deletion of TOP2A genes in a series of Taiwanese breast cancer.
Chen J, Chien H, Chen K, Hwang C, Chen H, Yeh K Medicine (Baltimore). 2017; 96(2):e5582.
PMID: 28079792 PMC: 5266154. DOI: 10.1097/MD.0000000000005582.
Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate.
Holst F World J Clin Oncol. 2016; 7(2):160-73.
PMID: 27081639 PMC: 4826962. DOI: 10.5306/wjco.v7.i2.160.